These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 7810037

  • 1. [Clinical-immunological disorders in uveitis in patients with Behçet's syndrome].
    Teplinskaia LE, Kaliberdina AF, Zaĭtseva NS, Bulanova TD, Katsnel'son LA.
    Vestn Oftalmol; 1994; 110(3):23-5. PubMed ID: 7810037
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Immunological studies on Behçet's and Harada's diseases. I. Cell-mediated immunity in Behçet's and Harada's diseases. II. HL-A antigens associated with Behçet's disease.
    Sugiura S, Sanefuji M, Ohno S.
    Mod Probl Ophthalmol; 1976; 16():267-78. PubMed ID: 1250232
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Proteomic surveillance of autoimmunity in Behcet's disease with uveitis: selenium binding protein is a novel autoantigen in Behcet's disease.
    Okunuki Y, Usui Y, Takeuchi M, Kezuka T, Hattori T, Masuko K, Nakamura H, Yudoh K, Usui M, Nishioka K, Kato T.
    Exp Eye Res; 2007 May; 84(5):823-31. PubMed ID: 17343851
    [Abstract] [Full Text] [Related]

  • 7. Conjunctival ulcers in Behçet's disease.
    Zamir E, Bodaghi B, Tugal-Tutkun I, See RF, Charlotte F, Wang RC, Wechsler B, LeHoang P, Anteby I, Rao NA.
    Ophthalmology; 2003 Jun; 110(6):1137-41. PubMed ID: 12799237
    [Abstract] [Full Text] [Related]

  • 8. [Diagnosis, immunopathogenesis, clinical picture and treatment of uveitis in nephropathies].
    Teplinskaia LE, Kaliberdina AF.
    Vestn Oftalmol; 2000 Jun; 116(5):39-42. PubMed ID: 11221380
    [Abstract] [Full Text] [Related]

  • 9. Uveitis in juvenile Behçet's disease: clinical course and visual outcome compared with adult patients.
    Kramer M, Amer R, Mukamel M, Snir M, Jaouni T, Friling R.
    Eye (Lond); 2009 Nov; 23(11):2034-41. PubMed ID: 19151650
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial.
    Tugal-Tutkun I, Mudun A, Urgancioglu M, Kamali S, Kasapoglu E, Inanc M, Gül A.
    Arthritis Rheum; 2005 Aug; 52(8):2478-84. PubMed ID: 16052571
    [Abstract] [Full Text] [Related]

  • 11. Down-regulation of IFN-gamma-producing CD56+ T cells after combined low-dose cyclosporine/prednisone treatment in patients with Behçet's uveitis.
    Ahn JK, Seo JM, Yu J, Oh FS, Chung H, Yu HG.
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2458-64. PubMed ID: 15980236
    [Abstract] [Full Text] [Related]

  • 12. Behçet's disease and streptococcal infection.
    Namba K, Ueno T, Okita M.
    Jpn J Ophthalmol; 1986 Jul; 30(4):385-401. PubMed ID: 3586405
    [Abstract] [Full Text] [Related]

  • 13. [Magnetic resonance of the encephalon in 17 patients with ocular Behçet's disease].
    Di Biasi C, Accorinti M, Trasimeni G, Pivetti Pezzi P, Melone A, Gualdi G.
    Radiol Med; 1997 Apr; 93(4):348-51. PubMed ID: 9244909
    [Abstract] [Full Text] [Related]

  • 14. [A phase II study of FK506 (tacrolimus) on refractory uveitis associated with Behçet's disease and allied conditions].
    Sakane T, Mochizuki M, Inaba G, Masuda K.
    Ryumachi; 1995 Oct; 35(5):802-13. PubMed ID: 8594659
    [Abstract] [Full Text] [Related]

  • 15. Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease.
    Stanford M, Whittall T, Bergmeier LA, Lindblad M, Lundin S, Shinnick T, Mizushima Y, Holmgren J, Lehner T.
    Clin Exp Immunol; 2004 Jul; 137(1):201-8. PubMed ID: 15196263
    [Abstract] [Full Text] [Related]

  • 16. A case of Behçet's disease associated with membranous nephropathy.
    Miura M, Tomino Y, Suga T, Endoh M, Nomoto Y, Sakai H, Furuya K, Kobayashi Y.
    Tokai J Exp Clin Med; 1984 Aug; 9(3):231-5. PubMed ID: 6537671
    [Abstract] [Full Text] [Related]

  • 17. Circulating immune complexes in active Behçet's disease.
    Gupta RC, O'Duffy JD, McDuffie FC, Meurer M, Jordon RE.
    Clin Exp Immunol; 1978 Nov; 34(2):213-8. PubMed ID: 737905
    [Abstract] [Full Text] [Related]

  • 18. Circulating soluble immume complexes in recurrent oral ulceration and Behçet's syndrome.
    Levinsky RJ, Lehner T.
    Clin Exp Immunol; 1978 May; 32(2):193-8. PubMed ID: 668196
    [Abstract] [Full Text] [Related]

  • 19. Fluorescein iris angiography and anterior segment fluorophotometry in patients with Behçet's disease.
    Yoshikawa K, Takahashi Y, Ohsone T, Wakatsuki Y, Kogure M.
    Jpn J Ophthalmol; 1987 May; 31(3):425-32. PubMed ID: 3430858
    [Abstract] [Full Text] [Related]

  • 20. [Clinical experience with thymostimulin (TP-1) therapy. Preliminary findings].
    Altomonte L, Zoli A, Siena D, Alessi F, Pestillo L, Mirone L.
    Minerva Med; 1986 Jun 23; 77(26):1243-7. PubMed ID: 3725151
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.